We are live on ! Find out more
OSCR icon

Oscar Health

133 hedge funds and large institutions have $342M invested in Oscar Health in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 47 increasing their positions, 30 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

638% more call options, than puts

Call options by funds: $1.15M | Put options by funds: $156K

57% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 30

7% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 27

0% more funds holding

Funds holding: 133133 (0)

4.16% less ownership

Funds ownership: 82.95%78.79% (-4.2%)

33% less funds holding in top 10

Funds holding in top 10: 96 (-3)

53% less capital invested

Capital invested by funds: $733M → $342M (-$391M)

Holders
133
Holders Change
Holders Change %
0%
% of All Funds
2.14%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.1%
New
29
Increased
47
Reduced
30
Closed
27
Calls
$1.15M
Puts
$156K
Net Calls
+$996K
Net Calls Change
-$955K
Name Holding Trade Value Shares
Change
Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$2.46M -$10.3K -3,298 -0.3%
DFO
27
Duquesne Family Office
New York
$2.45M
Charles Schwab
28
Charles Schwab
California
$2.08M +$91.3K +29,212 +4%
CSS
29
Cubist Systematic Strategies
Connecticut
$1.86M +$634K +202,808 +37%
Morgan Stanley
30
Morgan Stanley
New York
$1.52M +$428K +137,073 +29%
RC
31
RBF Capital
California
$1.35M +$1.72M +550,758 New
Point72 Asset Management
32
Point72 Asset Management
Connecticut
$1.32M +$1.68M +537,228 New
Tudor Investment Corp
33
Tudor Investment Corp
Connecticut
$1.28M +$786K +251,379 +93%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$1.2M +$721K +230,761 +89%
Fidelity Investments
35
Fidelity Investments
Massachusetts
$1.1M -$460 -147 -0%
VA
36
Verdad Advisers
Massachusetts
$1.1M +$1.4M +448,156 New
AQR Capital Management
37
AQR Capital Management
Connecticut
$1.01M +$717K +229,397 +126%
American Century Companies
38
American Century Companies
Missouri
$953K +$792K +253,346 +189%
Prudential Financial
39
Prudential Financial
New Jersey
$942K +$1.2M +383,085 New
Bank of New York Mellon
40
Bank of New York Mellon
New York
$938K +$3.78K +1,208 +0.3%
Bank of Montreal
41
Bank of Montreal
Ontario, Canada
$906K +$1.15M +366,934 New
Goldman Sachs
42
Goldman Sachs
New York
$861K -$990K -316,755 -48%
AG
43
Algert Global
California
$847K +$389K +124,360 +57%
GCM
44
Graham Capital Management
Connecticut
$785K +$365K +116,623 +58%
Mitsubishi UFJ Trust & Banking
45
Mitsubishi UFJ Trust & Banking
Japan
$746K -$2.6M -832,520 -73%
SFI
46
Susquehanna Fundamental Investments
Pennsylvania
$577K +$515K +164,594 +236%
Qube Research & Technologies (QRT)
47
Qube Research & Technologies (QRT)
United Kingdom
$543K +$689K +220,576 New
ECM
48
ExodusPoint Capital Management
New York
$521K -$236K -75,523 -26%
Assenagon Asset Management
49
Assenagon Asset Management
Luxembourg
$491K +$624K +199,635 New
AFM
50
Anson Funds Management
Texas
$467K +$594K +189,917 New

OSCR Hedge Fund Activity: Q4 2022 in Review

133 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Oscar Health (OSCR) for Q4 2022, worth a combined $342M — down 53% from $733M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new OSCR positions and 27 closed out — a net gain of 2 holders — while 47 added to existing stakes and 30 trimmed.

The largest buyer was BlackRock, adding an estimated $12M. The largest seller was Baillie Gifford & Co, cutting an estimated $60.2M.

  • 133 institutional investors held Oscar Health (OSCR) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $342M of Oscar Health stock for Q4 2022, down 53% quarter-over-quarter.
  • 29 funds opened new Oscar Health positions in Q4 2022 and 27 closed out, a net change of +2 holders.
  • The largest Oscar Health buyer in Q4 2022 was BlackRock, an estimated $12M added.
  • The largest Oscar Health seller in Q4 2022 was Baillie Gifford & Co, an estimated $60.2M sold.

Based on aggregated 13F filings for Q4 2022.